Bio-Connect

ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)

SEA940HU
Cloud-Clone Corp.
Product group Assays

Product SEA940HU is not available

Product not available

There may be an alternative product available, please contact our technical support team.

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Chemokine C-X-C-Motif Receptor 4 (CXCR4)
  • Delivery Days Customer
    12
  • Applications
    ELISA
  • Assay Detection Range
    0.156-10ng/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Chemokine C-X-C-Motif Receptor 4 (CXCR4) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 0.056ng/mL
  • Assay Test Principle
    The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Chemokine C-X-C-Motif Receptor 4 (CXCR4). Standards or samples are then added to the...
  • Assay Time
    3h
  • Certification
    Research Use Only
  • UNSPSC
    41116100
  • Species
    Human

References

  • A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity. Oglodek EA et al., 2016 Aug, Pharmacol Rep
    Read this paper
  • Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Oglodek EA et al., 2015 Dec, Pharmacol Rep
    Read this paper
  • Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression. Oglodek EA et al., 2014 Oct, Pharmacol Rep
    Read this paper
  • The non-alcoholic fraction of beer increases stromal cell derived factor 1 and the number of circulating endothelial progenitor cells in high cardiovascular risk subjects: a randomized clinical trial. Chiva-Blanch G et al., 2014 Apr, Atherosclerosis
    Read this paper